SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Automated Triplex (HBV, HCV and HIV) NAT Assay Systems for Blood Screening in India
11 references·1 citing·40 second hop
Automated Triplex (HBV, HCV and HIV) NAT Assay Systems for Blood Screening in India (2016)Automated Triplex (HBV, HCV and HIV) NAT …Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital. (2013)Individual donor nucleic acid…Evaluation of serological transfusion-transmitted viral diseases and mutliplex nucleic acid testing in malaysian blood donors (2013)Evaluation of serological tra…Evaluation of two, commercial, multi‐dye, nucleic acid amplification technology tests, for HBV/HCV/HIV‐1/HIV‐2 and B19V/HAV, for screening blood and plasma for further manufacture (2012)Evaluation of two, commercial…A study on optimization of plasma pool size for viral infectious markers in Indian blood donors using nucleic acid amplification testing (2012)A study on optimization of pl…International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)International survey on NAT t…Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms (2010)Refinement of a viral transmi…One‐year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations (2009)One‐year experience of nuclei…Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus (2008)Experience of German Red Cros…Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201 (2008)Comparison of the analytical …Residual infectious disease risk in screened blood transfusion from a high‐prevalence population: Santa Catarina, Brazil (2007)Residual infectious disease r…Risks of transfusion-transmitted infections: 2003 (2003)Risks of transfusion-transmit…Blood Donation Screening of Transfusion-Transmissible Viral Infection Using Two Different Nucleic Acid Testing (NAT) Platforms: A Single Tertiary Care Oncology Centre Experience (2022)Blood Donation Screening of T…Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Yield of HCV and HIV‐1 NAT after screening of 3.6 million blood donations in central Europe (2002)The prevalence of hepatitis A virus and parvovirus B19 in source‐plasma donors and whole blood donors in China (2015)The Brazilian experience of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in blood donors (2018)Anti‐ HB c screening – is it worth the effort? Results of a 10‐year surveillance programme covering more than 30 million donations in Germany (2019)Multicenter performance evaluation of a transcription‐mediated amplification assay for screening of human immunodeficiency virus‐1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations (2005)Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT) (2005)Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes (2009)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Motivations to donate blood: demographic comparisons (2002)The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)Undisclosed human immunodeficiency virus risk factors identified through a computer‐based questionnaire program among blood donors in B razil (2013)Use of quality rapid diagnostic testing for safe blood transfusion in resource-limited settings (2013)Seroprevalence and trends of transfusion transmitted infections at Harar blood bank in Harari regional state, Eastern Ethiopia: eight years retrospective study (2018)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Hepatitis B virus blood screening: unfinished agendas (2006)BLOOD DONORS AND BLOOD COLLECTION: Web interface–supported transmission risk assessment and cost‐effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands (2009)Nucleic acid testing (NAT) in high prevalence–low resource settings (2010)Reduction of the risk of transfusion‐transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5‐year review (2012)The Risk of Transfusion-Transmitted Viral Infections (1996)Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Quality and safety measures in transfusion practice: The experience of eight southern/eastern Mediterranean countries (2020)The Prevalence of Transfusion-transmitted Infections among Blood Donors in Hospital Universiti Sains Malaysia (2020)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa (2009)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes (2018)Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016 (2020)HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men (2021)Comparative analysis of triplex nucleic acid test assays in United States blood donors (2013)Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? (2013)History and Future of Nucleic Acid Amplification Technology Blood Donor Testing (2019)Transfusion Transmitted Infections in Armed Forces: Prevalence and Trends (2006)The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre. (2014)Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions (2009)Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India (2013)Screening Donated Blood for Transfusion Transmitted Infections by Serology along with NAT and Response Rate to Notification of Reactive Results: An Indian Experience (2014)Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety (2015)Nucleic acid amplification testing in Indian blood banks: A review with perspectives (2017)
this work references cited by second hop

References

  • 2011International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009191 cited
  • 2008Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus189 cited
  • 2010Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms131 cited
  • 2003Risks of transfusion-transmitted infections: 200397 cited
  • 2008Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 20152 cited
  • 2009One‐year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations48 cited
  • 2013Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital.48 cited
  • 2007Residual infectious disease risk in screened blood transfusion from a high‐prevalence population: Santa Catarina, Brazil44 cited
  • 2012Evaluation of two, commercial, multi‐dye, nucleic acid amplification technology tests, for HBV/HCV/HIV‐1/HIV‐2 and B19V/HAV, for screening blood and plasma for further manufacture27 cited
  • 2013Evaluation of serological transfusion-transmitted viral diseases and mutliplex nucleic acid testing in malaysian blood donors18 cited
  • 2012A study on optimization of plasma pool size for viral infectious markers in Indian blood donors using nucleic acid amplification testing

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

10 cited

Cited by

  • 2022Blood Donation Screening of Transfusion-Transmissible Viral Infection Using Two Different Nucleic Acid Testing (NAT) Platforms: A Single Tertiary Care Oncology Centre Experience6 cited